ysdaiuaytchkcp@hotmail.com pfp

[email protected]

@ysdaiuaytchkcp

128 Following
9 Followers


ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
🌐 𝐓𝐇𝐄 𝐈𝐍𝐓𝐄𝐑𝐍𝐄𝐓 𝐎𝐅 𝐎𝐏𝐄𝐍-𝐒𝐎𝐔𝐑𝐂𝐄 𝐈𝐒 𝐇𝐄𝐑𝐄 Something big is coming tomorrow… Pre-register for early access here: 👉 https://t.co/p0UZP1eWTZ https://t.co/C24dBBdTmj
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
RT @damobianyuan: 实话实说,项目有点拉胯,上一期的积分不作数,我白白跑了几千万的积分,一边骂一边继续跑,还有两天,兄弟们抓紧吧:https://t.co/LmLC4dhHeT #NEXUS #空投 https://t.co/XVfCmdoWc3
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
RT @wangni89: Monad中文区五子棋大赛参与要求 : 1:点赞关注并转发评论本条推文! 2:关注 @monad_xyz @monad_zw @lootgoapp 3:加入Monad电报中文频道 https://t.co/QVEVHgeynt 活动时间:1月14…
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
RT @Zhuzhaoqian666: $BIO 解决的痛点: 1.大多数生物制药公司只研究利润足够大的药物,而不是罕见病 2.整合subDAO的数据资源(专利,知识产权),不重复造轮子 3.投后流动性太差,缺乏及时的资本定价 https://t.co/l4z9E3nvv8其实…
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
RT @Zhuzhaoqian666: $BIO 解决的痛点: 1.大多数生物制药公司只研究利润足够大的药物,而不是罕见病 2.整合subDAO的数据资源(专利,知识产权),不重复造轮子 3.投后流动性太差,缺乏及时的资本定价 https://t.co/l4z9E3nvv8其实…
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
BIO Protocol Sign the Manifesto ? Go to https://t.co/b0RP78O8HZ Submit your information in the form below #bioacc
0 reply
0 recast
0 reaction

ysdaiuaytchkcp@hotmail.com pfp
[email protected]
@ysdaiuaytchkcp
RT @monad_xyz: Maybe the real Monad was the friends we made along the way
0 reply
0 recast
0 reaction